CompletedNCT03370341
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- The University of Texas at Dallas
- Condition
- Schizophrenia
TerminatedNCT03588728
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Pittsburgh
- Condition
- Schizophrenia
CompletedNCT03503318
This study exists to understand how the medication TV-46000 holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication TV-46000 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 13 Years to 65 Years
- Countries
- Bulgaria, United States
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Condition
- Schizophrenia
CompletedNCT01602263
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 79 Years
- Countries
- United States
- Sponsor
- Johns Hopkins University
- Condition
- Schizophrenia
CompletedNCT00330551
This study exists to compare options and see whether a guided support group offers something meaningfully different. Researchers are trying to understand whether a guided support group can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
TerminatedNCT04404712
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT02535923
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia
CompletedNCT04856657
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
CompletedNCT04010305
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- BioXcel Therapeutics Inc
- Condition
- Schizophrenia
CompletedNCT04567524
This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Lyndra Inc.
- Condition
- Schizophrenia
CompletedNCT05712928
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Drexel University
- Condition
- Schizophrenia
CompletedNCT03919994
This study exists to see whether the medication Long can play a useful role in care. Researchers are trying to understand what the medication Long could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Alkermes, Inc.
- Condition
- Schizophrenia
CompletedNCT02404155
This study exists to see whether the medication Clozapine is workable and worth testing more broadly. Researchers are trying to understand how people respond to the medication Clozapine in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT03769493
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Butler Hospital
- Condition
- Schizophrenia
CompletedNCT03281629
This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT04799717
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 10 Years to 18 Years
- Countries
- United States
- Sponsor
- Stanford University
- Condition
- Schizophrenia
CompletedNCT03860597
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
CompletedNCT05245539
This study exists to explore whether the medication CVL-231 could improve care and understanding. Researchers are trying to understand what the medication CVL-231 can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 30 Years to 60 Years
- Countries
- United States
- Sponsor
- Cerevel Therapeutics, LLC
- Condition
- Schizophrenia
CompletedNCT03893825
This study exists to understand how the medication TV-46000 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication TV-46000 can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 13 Years to 65 Years
- Countries
- Bulgaria, Canada, France, Israel, United States
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Condition
- Schizophrenia
CompletedNCT04709224
This study exists to learn from real-world information that can show how a medication treatment fits into care. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Schizophrenia
CompletedNCT00982982
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT02404194
This study exists to understand how brain scans or other body measurements holds up over time after the earliest research stage. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 15 Years to 30 Years
- Countries
- United States
- Sponsor
- Rush University Medical Center
- Condition
- Schizophrenia
TerminatedNCT00591318
This study exists to see whether the medication IV can play a useful role in care. Researchers are trying to understand whether the medication IV can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Research Foundation for Mental Hygiene, Inc.
- Condition
- Schizophrenia
CompletedNCT03504579
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Harvard Medical School (HMS and HSDM)
- Condition
- Schizophrenia
CompletedNCT03129360
This study exists to understand what helps blood tests and biological markers work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 16 Years to 35 Years
- Countries
- United States
- Sponsor
- NYU Langone Health
- Condition
- Schizophrenia